Bio-Rad Laboratories (BIO.B) Scheduled to Post Earnings on Thursday

Bio-Rad Laboratories (NYSE:BIO.B) is scheduled to release its earnings data after the market closes on Thursday, August 1st.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its earnings results on Tuesday, May 7th. The company reported $2.29 earnings per share for the quarter. Bio-Rad Laboratories had a negative net margin of 12.37% and a positive return on equity of 3.59%. The business had revenue of $610.82 million for the quarter.

Bio-Rad Laboratories Price Performance

Shares of NYSE:BIO.B opened at $294.23 on Tuesday. The firm has a fifty day moving average price of $284.71 and a two-hundred day moving average price of $305.85. The company has a debt-to-equity ratio of 0.13, a current ratio of 6.57 and a quick ratio of 4.89. Bio-Rad Laboratories has a one year low of $271.00 and a one year high of $373.78.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.